Skip to main content
Tech.euFundingExplorerBeta

seragy

seragy is a provider of a biomarker strategy platform focused on neurodegenerative diseases and other proteopathies.

seragy has raised €12M across 1 funding round from 3 investors, most recently a round in Oct 2026. Based in Hanover, Germany; active in Healthtech. Data as of 28 Oct 2026.

Hanover, Germanyseragy.com ↗
Healthtech
← All companies
Total raised
€12M
€12,000,000
Funding rounds
1
Investors
3
distinct backers
Active since
2026-10
latest 2026-10

Funding by year

EUR raised per year · 2026 YTD
seragy — funding by year — interactive chart.
Data table
seragy — funding by year
2026€12M

Signals

High confidence
Raise-next likelihood10
base rate 30% for Other
  • ▼ Raised very recently
  • ▼ Low backer re-investment

Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

1 round
DateStageAmountInvestors
2026-10-15Other€12MCommerzbank,the Mittelständische Beteiligungsgesellschaft (MBG),the State of Lower SaxonyView deal →

Investors

3
Commerzbankthe Mittelständische Beteiligungsgesellschaft (MBG)the State of Lower Saxony

Related news

Similar companies

same sector or country

Global coverage: FundingData